ID
24379
Description
Visit 2 Eligibility Checklist form Study ID: 208127/125 Clinical Study ID: 208127/125 (Ext-HAB-038 Month 90) Study Title: A double-blind, randomized study to evaluate the immunogenicity and reactogenicity of two different lots of GlaxoSmithKline Biologicals' combined hepatitis A / hepatitis B vaccine in healthy children between 6 and 15 years of age. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor:GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: Hepatitis A (Inactivated), Hepatitis B (Recombinant) Vaccine Trade Name: Twinrix Study Indication: Hepatitis A; Hepatitis B
Mots-clés
Versions (1)
- 30/07/2017 30/07/2017 -
Détendeur de droits
GlaxoSmithKline
Téléchargé le
30 juillet 2017
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 3.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Visit 2 Eligibility Checklist Biologicals HepA/HepB vaccine 208127/125
Visit 2 Eligibility Checklist Biologicals HepA/HepB vaccine 208127/125
Description
Criteria for study participation
Alias
- UMLS CUI-1
- C1512693
Description
Age
Type de données
boolean
Alias
- UMLS CUI [1]
- C0001779
Description
Good physical condition
Type de données
boolean
Alias
- UMLS CUI [1]
- C1142435
Description
NA = no answer
Type de données
boolean
Alias
- UMLS CUI [1]
- C0700589
Description
Written informed consent
Type de données
boolean
Alias
- UMLS CUI [1]
- C0021430
Description
if the written informed consent has been signed, enter the date of signature day/month/year
Type de données
date
Alias
- UMLS CUI [1]
- C2985782
Description
Criteria for exclusion of the study
Alias
- UMLS CUI-1
- C0680251
Description
Positive titres for hepatitis antibodies
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C0201473
- UMLS CUI [1,2]
- C0201478
- UMLS CUI [1,3]
- C0201480
- UMLS CUI [2]
- C0201477
Description
Elevated ALT or AST
Type de données
boolean
Alias
- UMLS CUI [1]
- C0201836
- UMLS CUI [2]
- C0201899
Description
History of diseases
Type de données
boolean
Alias
- UMLS CUI [1]
- C0018939
- UMLS CUI [2]
- C0023895
- UMLS CUI [3]
- C0022658
- UMLS CUI [4]
- C0018799
- UMLS CUI [5]
- C0035204
Description
Acute disease
Type de données
boolean
Alias
- UMLS CUI [1]
- C0001314
Description
Chronic alcohol consumption
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C0205191
- UMLS CUI [1,2]
- C0001948
Description
Hepatomegaly or right upper quadrant adominal pain
Type de données
boolean
Alias
- UMLS CUI [1]
- C0019209
- UMLS CUI [2]
- C0235299
Description
Chronic drug treatment
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C0205191
- UMLS CUI [1,2]
- C0013216
- UMLS CUI [2]
- C0021081
Description
Allergy stimulated by the vaccine
Type de données
boolean
Alias
- UMLS CUI [1]
- C0571550
Description
Participation in another clinical trial
Type de données
boolean
Alias
- UMLS CUI [1]
- C2348568
Description
Previous vaccination against hepatitis
Type de données
boolean
Alias
- UMLS CUI [1]
- C0419735
- UMLS CUI [2]
- C0474232
Description
Administrative Data
Alias
- UMLS CUI-1
- C1320722
Similar models
Visit 2 Eligibility Checklist Biologicals HepA/HepB vaccine 208127/125
C0201478 (UMLS CUI [1,2])
C0201480 (UMLS CUI [1,3])
C0201477 (UMLS CUI [2])
C0201899 (UMLS CUI [2])
C0023895 (UMLS CUI [2])
C0022658 (UMLS CUI [3])
C0018799 (UMLS CUI [4])
C0035204 (UMLS CUI [5])
C0001948 (UMLS CUI [1,2])
C0235299 (UMLS CUI [2])
C0013216 (UMLS CUI [1,2])
C0021081 (UMLS CUI [2])
C0474232 (UMLS CUI [2])